Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-Aminopyridine to Treat Skin Burns
NCT06596434Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in burn injury. Started Jan 2026; status: recruiting.
02
Drugs
dalfampridine
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT06596434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06596434.